au.\*:("ARMSTRONG, Terri S")
Results 1 to 9 of 9
Selection :
Clinical Course of Adult Patients With Ependymoma: Results of the Adult Ependymoma Outcomes ProjectARMSTRONG, Terri S; VERA-BOLANOS, Elizabeth; GILBERT, Mark R et al.Cancer. 2011, Vol 117, Num 22, pp 5133-5141, issn 0008-543X, 9 p.Article
The Impact of Symptom Interference Using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on Prediction of Recurrence in Primary Brain Tumor PatientsARMSTRONG, Terri S; VERA-BOLANOS, Elizabeth; GNING, Ibrahima et al.Cancer. 2011, Vol 117, Num 14, pp 3222-3228, issn 0008-543X, 7 p.Article
Congruence of Primary Brain Tumor Patient and Caregiver Symptom ReportARMSTRONG, Terri S; WEFEL, Jeffrey S; GNING, Ibrahima et al.Cancer. 2012, Vol 118, Num 20, pp 5026-5037, issn 0008-543X, 12 p.Article
Uncertainty, Mood States, and Symptom Distress in Patients With Primary Brain Tumors: Analysis of a Conceptual Model Using Structural Equation ModelingLIN LIN; CHIANG, Hui-Hsun; ACQUAYE, Alvina A et al.Cancer. 2013, Vol 119, Num 15, pp 2796-2806, issn 0008-543X, 11 p.Article
Clinical Utility of the MDASI-BT in Patients with Brain MetastasesARMSTRONG, Terri S; GNING, Ibrahima; MENDOZA, Tito R et al.Journal of pain and symptom management. 2009, Vol 37, Num 3, pp 331-340, issn 0885-3924, 10 p.Article
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialGILBERT, Mark R; MEIHUA WANG; MAHAJAN, Anita et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4085-4091, issn 0732-183X, 7 p.Article
Risk Factors for Fatigue Severity in Primary Brain Tumor PatientsARMSTRONG, Terri S; CRON, Stanley G; BOLANOS, Elizabeth Vera et al.Cancer. 2010, Vol 116, Num 11, pp 2707-2715, issn 0008-543X, 9 p.Article
A Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaGILBERT, Mark R; DIGNAM, James J; JERAJ, Robert et al.The New England journal of medicine. 2014, Vol 370, Num 8, pp 699-708, issn 0028-4793, 10 p.Article
Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed GlioblastomaARMSTRONG, Terri S; WEFEL, Jeffrey S; CHOUCAIR, Ali K et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4076-4084, issn 0732-183X, 9 p.Conference Paper